These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31177342)

  • 1. A review of the influence of mammographic density on breast cancer clinical and pathological phenotype.
    Shawky MS; Huo CW; Henderson MA; Redfern A; Britt K; Thompson EW
    Breast Cancer Res Treat; 2019 Sep; 177(2):251-276. PubMed ID: 31177342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium.
    Huo CW; Chew G; Hill P; Huang D; Ingman W; Hodson L; Brown KA; Magenau A; Allam AH; McGhee E; Timpson P; Henderson MA; Thompson EW; Britt K
    Breast Cancer Res; 2015 Jun; 17(1):79. PubMed ID: 26040322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
    Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
    Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program.
    Baré M; Torà N; Salas D; Sentís M; Ferrer J; Ibáñez J; Zubizarreta R; Sarriugarte G; Barata T; Domingo L; Castells X; Sala M
    Breast Cancer Res Treat; 2015 Nov; 154(2):403-15. PubMed ID: 26531756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
    Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
    Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammographically dense human breast tissue stimulates MCF10DCIS.com progression to invasive lesions and metastasis.
    Huo CW; Waltham M; Khoo C; Fox SB; Hill P; Chen S; Chew GL; Price JT; Nguyen CH; Williams ED; Henderson M; Thompson EW; Britt KL
    Breast Cancer Res; 2016 Oct; 18(1):106. PubMed ID: 27776557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between mammographic density and tumor characteristics in Chinese women with breast cancer.
    Li E; Guida JL; Tian Y; Sung H; Koka H; Li M; Chan A; Zhang H; Tang E; Guo C; Deng J; Hu N; Lu N; Gierach GL; Li J; Yang XR
    Breast Cancer Res Treat; 2019 Sep; 177(2):527-536. PubMed ID: 31254158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammographic features at primary breast cancer diagnosis in relation to recurrence-free survival.
    Lång K; Sturesdotter L; Bengtsson Y; Larsson AM; Sartor H
    Breast; 2024 Jun; 75():103736. PubMed ID: 38663074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women.
    Yoon TI; Kwak BS; Yi OV; Kim S; Um E; Yun KW; Shin HN; Lee S; Sohn G; Chung IY; Kim J; Ko BS; Lee JW; Son BH; Ahn SH; Kim HJ
    Breast Cancer Res Treat; 2019 Feb; 173(3):657-665. PubMed ID: 30377870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammographic tumour appearance is related to clinicopathological factors and surrogate molecular breast cancer subtype.
    Sturesdotter L; Sandsveden M; Johnson K; Larsson AM; Zackrisson S; Sartor H
    Sci Rep; 2020 Nov; 10(1):20814. PubMed ID: 33257731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derived mammographic masking measures based on simulated lesions predict the risk of interval cancer after controlling for known risk factors: a case-case analysis.
    Hinton B; Ma L; Mahmoudzadeh AP; Malkov S; Fan B; Greenwood H; Joe B; Lee V; Strand F; Kerlikowske K; Shepherd J
    Med Phys; 2019 Mar; 46(3):1309-1316. PubMed ID: 30697755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammographic density-a review on the current understanding of its association with breast cancer.
    Huo CW; Chew GL; Britt KL; Ingman WV; Henderson MA; Hopper JL; Thompson EW
    Breast Cancer Res Treat; 2014 Apr; 144(3):479-502. PubMed ID: 24615497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and tumor characteristics of interval cancers by mammographic density.
    Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
    J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.
    Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH
    APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of surveillance mammography outcomes in women with a personal history of breast cancer.
    Lowry KP; Braunstein LZ; Economopoulos KP; Salama L; Lehman CD; Gazelle GS; Halpern EF; Giess CS; Taghian AG; Lee JM
    Breast Cancer Res Treat; 2018 Aug; 171(1):209-215. PubMed ID: 29748762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of breast cancers detected in the Verona screening program following transition to digital breast tomosynthesis screening with cancers detected at digital mammography screening.
    Caumo F; Romanucci G; Hunter K; Zorzi M; Brunelli S; Macaskill P; Houssami N
    Breast Cancer Res Treat; 2018 Jul; 170(2):391-397. PubMed ID: 29557996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammographic density and prognosis in primary breast cancer patients.
    Heindl F; Fasching PA; Hein A; Hack CC; Heusinger K; Gass P; Pöschke P; Stübs FA; Schulz-Wendtland R; Hartmann A; Erber R; Beckmann MW; Meyer J; Häberle L; Jud SM; Emons J
    Breast; 2021 Oct; 59():51-57. PubMed ID: 34157655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammographic breast density is associated with the development of contralateral breast cancer.
    Raghavendra A; Sinha AK; Le-Petross HT; Garg N; Hsu L; Patangan M; Bevers TB; Shen Y; Banu A; Tripathy D; Bedrosian I; Barcenas CH
    Cancer; 2017 Jun; 123(11):1935-1940. PubMed ID: 28135395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do mammographic tumor features in breast cancer relate to breast density and invasiveness, tumor size, and axillary lymph node involvement?
    Sartor H; Borgquist S; Hartman L; Olsson Å; Jawdat F; Zackrisson S
    Acta Radiol; 2015 May; 56(5):536-44. PubMed ID: 24814360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary investigation of mammographic density among women in Riyadh: association with breast cancer risk factors and implications for screening practices.
    Albeshan SM; Hossain SZ; Mackey MG; Peat JK; Al Tahan FM; Brennan PC
    Clin Imaging; 2019; 54():138-147. PubMed ID: 30639525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.